Advertise
NEWSLETTER
Serina advances SER-252 Par...
FDA accepts review for Nano...
MetaVia data show DA-1726 c...
Coya’s combination dr...
Alzheon reports Phase 3 win...
Serina advances SER-252 Par...
FDA accepts review for Nano...
MetaVia data show DA-1726 c...
Coya’s combination dr...
Alzheon reports Phase 3 win...
Longevity finance

Primetime Partners get ready for Longevity primetime

Legal & General and Edinburgh University

L&G escalates investment into research for social care

Longevity investing: A UBS Investor Watch survey shows that investors would sacrifice wealth for an extra ten years of healthy life.

Would you invest $1000 per week to live longer?

Money can’t buy happiness – but it can buy Longevity; this updated report from UBS identifies

Longevity investment is growing and we're seeing a mixture of funds and investment platforms. We chat with the founder of R42 Group

Talking Longevity investment and risk with R42 Group

Academic proposes that FinTech and InsurTech can be a key enabler of new financial approaches for older people. Credit: Moshe Brin

Longevity FinTech: a new contract between finance and aging

Selfie biomarkers: AI and insurtech implications for Longevity

Phil Newman

Why Longevity, why now?

Source: Magaretta Colangelo and Dmitry Kaminskiy – LONGEVITY INDUSTRY 1.0

Megatrends: longer lives and finance sector disruption

Longevity industry expert Margaretta Colangelo says we are on the brink of a Longevity financial revolution.

From health span to wealth span

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form